Feasibility Study to Use Biosensing Devices to Monitor PA and Resp. Function in Smokers w and w/o Resp. Symptoms/COPD
A Proof-of-concept, Open-label, Feasibility Study to Evaluate Mobile Applications and Biosensing (mHealth) Devices to Monitor Physical Activity and Respiratory Function in Smokers With and Without Respiratory Symptoms/COPD
Sponsor: Kazakhstan Academy of Preventive Medicine
Listed as NCT04081961, this observational or N/A phase trial focuses on Activity Trackers and Mobile Applications and remains completed. Sponsored by Kazakhstan Academy of Preventive Medicine, it has been updated 10 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Feb 2025 — Present [monthly]
Completed
-
Sep 2024 — Feb 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed
-
Apr 2020 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Feb 2020 — Apr 2020 [monthly]
Active Not Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Active Not Recruiting
-
Oct 2019 — Jan 2020 [monthly]
Active Not Recruiting
First recorded
Jun 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Kazakhstan Academy of Preventive Medicine
- Philip Morris International
- Synergy Research Group
For direct contact, visit the study record on ClinicalTrials.gov .